Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rachel S. Sousa"'
Autor:
Rena Emond, Jason I. Griffiths, Vince Kornél Grolmusz, Aritro Nath, Jinfeng Chen, Eric F. Medina, Rachel S. Sousa, Timothy Synold, Frederick R. Adler, Andrea H. Bild
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract The interplay of positive and negative interactions between drug-sensitive and resistant cells influences the effectiveness of treatment in heterogeneous cancer cell populations. Here, we study interactions between estrogen receptor-positive
Externí odkaz:
https://doaj.org/article/ace0baddb0824ad0a9092e60d8e05400
Autor:
Shannon N Geels, Alexander Moshensky, Rachel S Sousa, Benjamin L Walker, Rima Singh, Giselle Gutierrez, Michael Hwang, Thorsten R Mempel, Qing Nie, Shivashankar Othy, Francesco Marangoni
Publikováno v:
bioRxiv
SUMMARYPD-1 blockade unleashes the potent antitumor activity of CD8 cells but can also promote immunosuppressive T regulatory (Treg) cells, which may worsen response to immunotherapy. Tumor Treg inhibition is a promising strategy to overcome therapeu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ffddb517949b0983b73039083b78c90
https://europepmc.org/articles/PMC10245792/
https://europepmc.org/articles/PMC10245792/
Autor:
Rena Emond, Jason I. Griffiths, Vince Kornél Grolmusz, Aritro Nath, Jinfeng Chen, Eric F. Medina, Rachel S. Sousa, Frederick R. Adler, Andrea H. Bild
The interplay of positive and negative interactions between drug sensitive and resistant cells determines the efficacy of treatment in heterogeneous cancer cell populations. We developed isogenic estrogen receptor positive (ER+) breast cancer cell li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4c4c43ff84441b4ea5da0cdca2c6d4e
https://doi.org/10.1101/2021.02.01.429214
https://doi.org/10.1101/2021.02.01.429214